Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: J Urol. 2009 Apr 17;181(6):2806–2815. doi: 10.1016/j.juro.2009.01.096

Figure 4.

Figure 4

Treatment with pVAX-hSlo and/or tadalafil improved erectile function. A, time of longest visually observed erection in seconds. B, ICP/BP response after electrostimulation at 0.75, 4 and 10 mA following various treatments to improve erectile function. Plus sign indicates 1,000 µg pVAX-hSlo intracorporeally injected 1 month before experiment and/or 2.5 mg/kg tadalafil administered orally 2 hours before erectile function evaluation. Error bars indicate animal with greatest ICP/BP difference from average in 5 animals. Single asterisk indicates significantly different vs control (p <0.05). Double asterisks indicate that tadalafil plus pVAX-hSlo was significantly different from pVAX-hSlo alone (p <0.05).